1. EachPod

ReachMD CME - Podcast

ReachMD CME

 ReachMD

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, cardiology, women's health and more. And our CME library is continuously growing, every quarter.

Health Medicine Science & Medicine
Update frequency
every day
Episodes
499
Years Active
2019 - 2025
Share to:
Incorporating guideline-concordant care for patients with CLL/SLL relapsing after 2 prior lines of therapy

Incorporating guideline-concordant care for patients with CLL/SLL relapsing after 2 prior lines of therapy

Thu 23 Jan 2025
Guideline-recommended treatment options for patients with CLL/SLL and MCL that have progressed following a covalent BTK inhibitor

Guideline-recommended treatment options for patients with CLL/SLL and MCL that have progressed following a covalent BTK inhibitor

Thu 23 Jan 2025
Clinical trial evidence that drives current guidelines for patients with CLL/SLL and MCL receiving third-line therapies

Clinical trial evidence that drives current guidelines for patients with CLL/SLL and MCL receiving third-line therapies

Thu 23 Jan 2025
Evaluation and Management of AKI in Cirrhosis: At the Interface of Gastroenterology and Nephrology

Evaluation and Management of AKI in Cirrhosis: At the Interface of Gastroenterology and Nephrology

Fri 17 Jan 2025
Beyond the Symptoms: The True Impact of gMG on Patients' Lives

Beyond the Symptoms: The True Impact of gMG on Patients' Lives

CME credits: 1.00
Valid until: 17-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/beyond-the-symptoms-the-true-impact-of-gmg-on-patients-lives/32235/

The burden of generali…

Fri 17 Jan 2025
Diagnosing gMG: Navigating Current Tools and Approaches

Diagnosing gMG: Navigating Current Tools and Approaches

CME credits: 1.00
Valid until: 17-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/diagnosing-gmg-navigating-current-tools-and-approaches/32238/

The burden of generalized my…

Fri 17 Jan 2025
FcRn Antagonists in Myasthenia Gravis: A New Era in Targeted Therapy

FcRn Antagonists in Myasthenia Gravis: A New Era in Targeted Therapy

CME credits: 1.00
Valid until: 17-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/fcrn-antagonists-in-myasthenia-gravis-a-new-era-in-targeted-therapy/32242/

The burden of g…

Fri 17 Jan 2025
Optimizing FcRn Therapy: Addressing and Reducing Adverse Reactions

Optimizing FcRn Therapy: Addressing and Reducing Adverse Reactions

CME credits: 1.00
Valid until: 17-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/optimizing-fcrn-therapy-addressing-and-reducing-adverse-reactions/32243/

The burden of gen…

Fri 17 Jan 2025
Understanding Disease Progression: The Shift From Ocular to Generalized MG

Understanding Disease Progression: The Shift From Ocular to Generalized MG

CME credits: 1.00
Valid until: 17-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/understanding-disease-progression-the-shift-from-ocular-to-generalized-mg/32236/

The burde…

Fri 17 Jan 2025
Balancing Risk and Benefit: Traditional MG Treatments and Medications to Avoid

Balancing Risk and Benefit: Traditional MG Treatments and Medications to Avoid

Fri 17 Jan 2025
Precision Medicine in Myasthenia Gravis: Crafting Personalized Treatment Strategies

Precision Medicine in Myasthenia Gravis: Crafting Personalized Treatment Strategies

Fri 17 Jan 2025
The Science Behind FcRn Antagonists: A Deep Dive Into Their Mechanism of Action

The Science Behind FcRn Antagonists: A Deep Dive Into Their Mechanism of Action

Fri 17 Jan 2025
Life-Threatening Events: Understanding and Preventing Myasthenic Crisis

Life-Threatening Events: Understanding and Preventing Myasthenic Crisis

CME credits: 1.00
Valid until: 17-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/life-threatening-events-understanding-and-preventing-myasthenic-crisis/32237/

The burden o…

Fri 17 Jan 2025
Autoantibodies in MG: Their Role in Diagnosis and Treatment

Autoantibodies in MG: Their Role in Diagnosis and Treatment

CME credits: 1.00
Valid until: 17-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/autoantibodies-in-mg-their-role-in-diagnosis-and-treatment/32239/

The burden of generalize…

Fri 17 Jan 2025
Unique New Strategies for the Pharmacologic Treatment of Dry Eye Disease: Focus

Unique New Strategies for the Pharmacologic Treatment of Dry Eye Disease: Focus

Thu 16 Jan 2025
Breaking the Cycle: Addressing Hyperkalemia in CKD and Heart Failure to Optimize RAASi Therapy

Breaking the Cycle: Addressing Hyperkalemia in CKD and Heart Failure to Optimize RAASi Therapy

Wed 15 Jan 2025
Maximizing Myeloma Outcomes With GPRC5D-Directed Therapy: Practical Expert Case Studies and Best Practices

Maximizing Myeloma Outcomes With GPRC5D-Directed Therapy: Practical Expert Case Studies and Best Practices

Wed 15 Jan 2025
Chairperson's Perspective: Novel Treatments for Newly Diagnosed Ph+ CML-CP: Striking the Balance of Treatment With Patient Goals and QoL

Chairperson's Perspective: Novel Treatments for Newly Diagnosed Ph+ CML-CP: Striking the Balance of Treatment With Patient Goals and QoL

Tue 14 Jan 2025
Chemotherapy Strategies for Metastatic PDAC

Chemotherapy Strategies for Metastatic PDAC

CME credits: 0.25
Valid until: 13-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/chemotherapy-strategies-for-metastatic-pdac/26435/

Pancreatic ductal adenocarcinoma, other…

Mon 13 Jan 2025
Diagnosis and Management of Metastatic PDAC

Diagnosis and Management of Metastatic PDAC

CME credits: 0.25
Valid until: 13-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/diagnosis-and-management-of-metastatic-pdac/26434/

Pancreatic ductal adenocarcinoma, other…

Mon 13 Jan 2025
Disclaimer: The podcast and artwork embedded on this page are the property of ReachMD. This content is not affiliated with or endorsed by eachpod.com.